Equities research analysts at StockNews.com began coverage on shares of GEE Group (NYSE:JOB – Get Free Report) in a report issued on Sunday. The firm set a “buy” rating on the stock.
GEE Group Price Performance
GEE Group stock opened at $0.24 on Friday. The firm has a market cap of $26.43 million, a P/E ratio of -1.22 and a beta of 0.54. The business has a fifty day moving average of $0.25 and a two-hundred day moving average of $0.28. GEE Group has a twelve month low of $0.22 and a twelve month high of $0.55.
Institutional Trading of GEE Group
An institutional investor recently raised its position in GEE Group stock. Renaissance Technologies LLC grew its holdings in shares of GEE Group Inc. (NYSE:JOB – Free Report) by 17.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,163,672 shares of the company’s stock after purchasing an additional 176,043 shares during the period. Renaissance Technologies LLC owned approximately 1.07% of GEE Group worth $357,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 30.38% of the company’s stock.
About GEE Group
GEE Group Inc provides permanent and temporary professional and industrial staffing and placement services in the United States. The company operates through two segments, Industrial Staffing Services and Professional Staffing Services. It offers placement of information technology, accounting, finance, office, engineering, engineering professionals for direct hire and contract staffing services, and data entry assistants; and temporary staffing services for industrial clients.
Recommended Stories
- Five stocks we like better than GEE Group
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Effectively Use the MarketBeat Ratings Screener
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 3 Warren Buffett Stocks to Buy Now
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for GEE Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GEE Group and related companies with MarketBeat.com's FREE daily email newsletter.